TBK1 and infection: When we inhibited the interferon-alpha/beta receptor (IFNAR), we found that silencing IFNAR does not significantly alter infection (Fig 5), confirming our hypothesis that TBK1 mainly exerts its anti-CVB role through the autophagy pathway.